Which glycopeptide agent is associated with Red Man's Syndrome?

Vancomycin is the glycopeptide agent that is associated with Red Man's Syndrome. This syndrome is characterized by flushing and an erythematous rash that primarily affects the face, neck, and upper body. It can occur when vancomycin is infused too quickly, leading to a histamine release, which is responsible for these symptoms.

The risk of developing Red Man's Syndrome is primarily related to the infusion rate of vancomycin. To minimize this risk, it is recommended to infuse the medication over a period of at least 60 minutes, or slower if the patient starts to experience symptoms.

While other options listed are important antibiotics, they do not have the same association with Red Man's Syndrome. Chloramphenicol, clindamycin, and cephalosporins do not typically cause this specific reaction, making vancomycin the only agent linked to this syndrome in clinical practice. Understanding this association helps in providing safe and effective nursing care when administering antibiotics.